Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury
| Autor: | Osamu Tasaki, Hisashi Sugimoto, Goro Tajima, Hiroshi Tanaka, Kentaro Kajino, Hideo Hosotubo, Tomoyoshi Mouri, Tadahiko Shiozaki, Takeshi Shimazu, Kieko Fuijita, Haruhiko Nakae, Toshiaki Hayakata |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Adolescent Traumatic brain injury Anti-Inflammatory Agents Brain damage Critical Care and Intensive Care Medicine Gastroenterology Proinflammatory cytokine Cerebrospinal fluid Intensive care Internal medicine Pressure Medicine Humans Intracranial pressure Aged Cerebrospinal Fluid Inflammation business.industry Tumor Necrosis Factor-alpha Head injury Glasgow Coma Scale Middle Aged medicine.disease Prognosis Interleukin-10 Treatment Outcome Anesthesia Brain Injuries Emergency Medicine Female medicine.symptom business Interleukin-1 |
| Zdroj: | Shock (Augusta, Ga.). 23(5) |
| ISSN: | 1073-2322 |
| Popis: | In our previous study of patients with early-phase severe traumatic brain injury (TBI), the anti-inflammatory interleukin (IL)-10 concentration was lower in cerebrospinal fluid (CSF) than in serum, whereas proinflammatory IL-1beta and tumor necrosis factor (TNF)-alpha concentrations were higher in CSF than in serum. To clarify the influence of additional injury on this disproportion between proinflammatory and anti-inflammatory mediators, we compared their CSF and serum concentrations in patients with severe TBI with and without additional injury. All 35 study patients (18 with and 17 without additional injury) had a Glasgow Coma Scale score of 8 or less upon admission. With the exception of additional injury, clinical characteristics did not differ significantly between groups. CSF and serum concentrations of two proinflammatory mediators (IL-1beta and TNF-alpha,) and three anti-inflammatory mediators (IL-1 receptor antagonist [IL-1ra], soluble TNF receptor-I [sTNFr-I], and IL-10) were measured and compared at 6 h after injury. CSF concentrations of proinflammatory mediators were much higher than the corresponding serum concentrations in both patient groups (P < 0.001). In contrast, serum concentrations of anti-inflammatory mediators were much higher than the paired CSF concentrations in patients with additional injury (P < 0.001), but serum concentrations were lower than or equal to the corresponding CSF concentrations in patients without additional injury. CSF concentrations of IL-1beta, IL-1ra, sTNFr-I, and IL-10 were significantly higher (P < 0.01 for all) in patients with high intracranial pressure (ICP; n = 11) than in patients with low ICP (n = 24), and were also significantly higher (P < 0.05 for all) in patients with an unfavorable outcome (n = 14) than in patients with a favorable outcome (n = 21). These findings indicate that increased serum concentrations of anti-inflammatory mediators after severe TBI are mainly due to additional extracranial injury. We conclude that anti-inflammatory mediators in CSF may be useful indicators of the severity of brain damage in terms of ICP as well as overall prognosis of patients with severe TBI. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|